Their results support the notion that probiotic or synbiotic intake in individuals with T2DM may reduce CRP, TNF-α, and MDA and increase TAC and GSH but have no effects on IL-6, adiponectin, and leptin when compared to the control group (Naseri et al., 2023) [57]. The gene discussed is TNF; the disease is type 2 diabetes mellitus.